Logo der Universitätsmedizin Mainz


  • Gehring S, Kowalzik F, Okasha O, Engelmann T, Schreiner D, Jensen C, Mähringer-Kunz A, Hartig-Merkel W, Mai Phuong Tran T, Oostvogels C, Verstraeten T. A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines. PLoS One. 2024 Jan 30;19(1):e0294025. doi: 10.1371/journal.pone.0294025
  • Koliopoulos P, Kayange N, Jensen C, Gröndahl B, Eichmann J, Daniel T, Huth F, Eckert T, Klamm N, Follmann M, Medina-Montaño GC, Hokororo A, Pretsch L, Klüber J, Schmidt C, Züchner A, Addo MM, Okamo B, Mshana SE, Gehring S. Challenges in Diagnosing and Treating Acutely Febrile Children with Suspected Malaria at Health Care Facilities in the Lake Mwanza Region of Tanzania. Am J Trop Med Hyg. 2023 Dec 26;110(2):202-208. doi: 10.4269/ajtmh.23-0254.
  • Kayange N, Hau DK, Pain K, Mshana SE, Peck R, Gehring S, Groendahl B, Koliopoulos P, Revocatus B, Msaki EB, Malande O. Seroprevalence of Dengue and Chikungunya Virus Infections in Children Living in Sub-Saharan Africa: Systematic Review and Meta-Analysis. Children (Basel). 2023 Oct 7;10(10):1662. doi: 10.3390/children10101662.
  • Calderon-Ruiz P, Haist G, Mascus A, Holguin-Rocha AF, Koliopoulos P, Daniel T, Velez G, Londono-Renteria B, Gröndahl B, Tobon-Castano A, Gehring S. Multiplex Reverse Transcription Polymerase Chain Reaction Combined with a Microwell Hybridization Assay Screening for Arbovirus and Parasitic Infections in Febrile Patients Living in Endemic Regions of Colombia. Trop Med Infect Dis. 2023 Oct 6;8(10):466. doi: 10.3390/tropicalmed8100466.
  • Rodenak-Kladniew B, Castro MA, Gambaro RC, Girotti J, Cisneros JS, Viña S, Padula G, Crespo R, Castro GR, Gehring S, Chain CY, Islan GA. Cytotoxic Screening and Enhanced Anticancer Activity of Lippia alba and Clinopodium nepeta Essential Oils-Loaded Biocompatible Lipid Nanoparticles against Lung and Colon Cancer Cells. Pharmaceutics. 2023 Jul 29;15(8):2045. doi: 10.3390/pharmaceutics15082045.
  • Kaps L, Limeres MJ, Schneider P, Svensson M, Zeyn Y, Fraude S, Cacicedo ML, Galle PR, Gehring S, Bros M. Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. Int J Mol Sci. 2023 Jul 24;24(14):11869. doi: 10.3390/ijms241411869.
  • Knoll RL, Jarquín-Díaz VH, Klopp J, Kemper A, Hilbert K, Hillen B, Pfirrmann D, Simon P, Bähner V, Nitsche O, Gehring S, Markó L, Forslund SK, Poplawska K. Resilience and stability of the CF- intestinal and respiratory microbiome during nutritional and exercise intervention. BMC Microbiol. 2023 Feb 21;23(1):44. doi: 10.1186/s12866-023-02788-y.
  • Wirsching S, Fichter M, Cacicedo ML, Landfester K, Gehring S. Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase. Int J Mol Sci. 2022 Oct 18;23(20):12444. doi: 10.3390/ijms232012444.
  • Cacicedo ML, Limeres MJ, Gehring S. mRNA-Based Approaches to Treating Liver Diseases. Cells. 2022 Oct 21;11(20):3328. doi: 10.3390/cells11203328.
  • Cacicedo ML, Weinl-Tenbruck C, Frank D, Limeres MJ, Wirsching S, Hilbert K, Pasha Famian MA, Horscroft N, Hennermann JB, Zepp F, Chevessier-Tünnesen F, Gehring S. Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice. Front Bioeng Biotechnol. 2022 Oct 7;10:993298. doi: 10.3389/fbioe.2022.993298.
  • Gambaro RC, Berti IR, Cacicedo ML, Gehring S, Alvarez VA, Castro GR, Seoane A, Padula G, Islan GA. Colloidal delivery of vitamin E into solid lipid nanoparticles as a potential complement for the adverse effects of anemia treatment. Chem Phys Lipids. 2022 Nov;249:105252. doi: 10.1016/j.chemphyslip.2022.105252.
  • Wirsching S, Machtakova M, Borgans F, Pretsch L, Fichter M, Cacicedo ML, Thérien-Aubin H, Landfester K, Gehring S. OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells. Front Pediatr. 2022 Sep 13;10:966113. doi: 10.3389/fped.2022.966113.
  • Medina-Montano C, Rivero Berti I, Gambaro RC, Limeres MJ, Svensson M, Padula G, Chain CY, Cisneros JS, Castro GR, Grabbe S, Bros M, Gehring S, Islan GA, Cacicedo ML. Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells. Pharmaceutics. 2022 Aug 2;14(8):1611. doi: 10.3390/pharmaceutics14081611.
  • Cacicedo ML, Weinl-Tenbruck C, Frank D, Wirsching S, Straub BK, Hauke J, Okun JG, Horscroft N, Hennermann JB, Zepp F, Chevessier-Tünnesen F, Gehring S. mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model. Mol Ther Methods Clin Dev. 2022 Jul 15;26:294-308. doi: 10.1016/j.omtm.2022.07.006.
  • Medina-Montano C, Cacicedo ML, Svensson M, Limeres MJ, Zeyn Y, Chaves-Giraldo JE, Röhrig N, Grabbe S, Gehring S, Bros M. Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation. Int J Mol Sci. 2022 Jun 11;23(12):6543. doi: 10.3390/ijms23126543.
  • Wirsching S, Harder L, Heymanns M, Gröndahl B, Hilbert K, Kowalzik F, Meyer C, Gehring S. Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2. Front Immunol. 2022 Apr 20;13:800070. doi: 10.3389/fimmu.2022.800070.
  • Klopp J, Ferretti P, Meyer CU, Hilbert K, Haiß A, Marißen J, Henneke P, Hudalla H, Pirr S, Viemann D, Zemlin M, Forslund SK, Härtel C, Bork P, Gehring S, Van Rossum T; the PRIMAL Consortium. Meconium Microbiome of Very Preterm Infants across Germany. mSphere. 2022 Feb 23;7(1):e0080821. doi: 10.1128/msphere.00808-21.
  • Runkel S, Kowalzik F, Gehring S, Winter J, Kloeckner R, Mahringer-Kunz A, Viertel A, Grandt CL, Marron M, Seifert-Hitzler S, Hitzler WE. Longitudinal Study of the Signal Strength in two Serologic Assays for Detection of SARS-CoV-2 Specific Antibodies. Clin Lab. 2021 Dec 1;67(12). doi: 10.7754/Clin.Lab.2021.210441.
  • Machtakova M, Wirsching S, Gehring S, Landfester K, Thérien-Aubin H.
  • Controlling the semi-permeability of protein nanocapsules influences the cellular response to macromolecular payloads. J Mater Chem B. 2021 Oct 20;9(40):8389-8398. doi: 10.1039/d1tb01368h.
  • Li M, Jiang S, Haller A, Wirsching S, Fichter M, Simon J, Wagner M, Mailänder V, Gehring S, Crespy D, Landfester K. Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasone. Nanoscale Horiz. 2021 Sep 27;6(10):791-800. doi: 10.1039/d1nh00266j.
  • Kowalzik F, Schreiner D, Jensen C, Teschner D, Gehring S, Zepp F. mRNA-Based Vaccines. Vaccines (Basel). 2021 Apr 15;9(4):390. doi: 10.3390/vaccines9040390.
  • Huth PFB, Addo M, Daniel T, Groendahl B, Hokororo A, Koliopoulos P, Mshana S, Pretsch L, Schmidt C, Zuechner A, Gehring S, Kayange N. Extensive Antibiotic and Antimalarial Prescription Rate among Children with Acute Febrile Diseases in the Lake Victoria Region, Tanzania. J Trop Pediatr. 2021 Jan 29;67(1):fmaa135. doi: 10.1093/tropej/fmaa135.
  • Koliopoulos P, Kayange NM, Daniel T, Huth F, Gröndahl B, Medina-Montaño GC, Pretsch L, Klüber J, Schmidt C, Züchner A, Ulbert S, Mshana SE, Addo M, Gehring S. Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards. Malar J. 2021 Feb 1;20(1):66. doi: 10.1186/s12936-021-03595-4.
  • Simon J, Kuhn G, Fichter M, Gehring S, Landfester K, Mailänder V. Unraveling the In Vivo Protein Corona. Cells. 2021 Jan 12;10(1):132. doi: 10.3390/cells10010132.
  • Kidszun A, Neurohr A, Gröndahl B, Tippmann S, Schreiner D, Winter J, Mahmoudpour SH, Gehring S, Mildenberger E. Low Frequency of Viral Respiratory Tract Infections During Family-Centered Neonatal Intensive Care: Results of a Prospective Surveillance Study. Front Pediatr. 2020 Nov 16;8:606262. doi: 10.3389/fped.2020.606262.
  • Kwiyolecha E, Groendahl B, Okamo B, Kayange N, Manyama F, Kidenya BR, Mahamba DC, Msanga DR, Gehring S, Majigo M, Mshana SE, Mirambo MM. Patterns of viral pathogens causing upper respiratory tract infections among symptomatic children in Mwanza, Tanzania. Sci Rep. 2020 Oct 28;10(1):18490. doi: 10.1038/s41598-020-74555-2.
  • Runkel S, Kowalzik F, Gehring S, Winter J, Grandt CL, Marron M, Seifert-Hitzler S, Hitzler WE. Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic. C
  • Cacicedo ML, Medina-Montano C, Kaps L, Kappel C, Gehring S, Bros M. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy. Cells. 2020 Aug 28;9(9):1985. doi: 10.3390/cells9091985.
  • Knoll RL, Klopp J, Bonewitz G, Gröndahl B, Hilbert K, Kohnen W, Weise K, Plachter B, Hitzler W, Kowalzik F, Runkel S, Zepp F, Winter J, Cacicedo ML, Gehring S. Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit. Pediatr Infect Dis J. 2020 Nov;39(11):e336-e339. doi: 10.1097/INF.0000000000002866.
  • Reischl AT, Schreiner D, Poplawska K, Kidszun A, Zepp F, Gröndahl B, Gehring S. The clinical impact of PCR-based point-of-care diagnostic in respiratory tract infections in children. J Clin Lab Anal. 2020 May;34(5):e23203. doi: 10.1002/jcla.23203
  • Jiang S, Prozeller D, Pereira J, Simon J, Han S, Wirsching S, Fichter M, Mottola M, Lieberwirth I, Morsbach S, Mailänder V, Gehring S, Crespy D, Landfester K. Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsules. Nanoscale. 2020 Jan 28;12(4):2626-2637. doi: 10.1039/c9nr09879h.
  • Marißen J, Haiß A, Meyer C, Van Rossum T, Bünte LM, Frommhold D, Gille C, Goedicke-Fritz S, Göpel W, Hudalla H, Pagel J, Pirr S, Siller B, Viemann D, Vens M, König I, Herting E, Zemlin M, Gehring S, Bork P, Henneke P, Härtel C; PRIMAL consortium. Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocol. BMJ Open. 2019 Nov 21;9(11):e032617. doi: 10.1136/bmjopen-2019-032617.
  • Busch MA, Gröndahl B, Knoll RL, Pretsch L, Doganci A, Hoffmann I, Kullmer U, Bähner V, Zepp F, Meyer CU, Gehring S. Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis. Pediatr Res. 2020 Apr;87(5):839-846. doi: 10.1038/s41390-019-0486-5
  • Schreiner D, Groendahl B, Puppe W, Off HNT, Poplawska K, Knuf M, Meyer CU, Reischl AT, Gehring S. High antibiotic prescription rates in hospitalized children with human metapneumovirus infection in comparison to RSV infection emphasize the value of point-of-care diagnostics. Infection. 2019 Apr;47(2):201-207. doi: 10.1007/s15010-018-1194-5. Epub 2018 Aug 21.
  • Meyer CU, Klopp J, Knoll R, Gehring S Beeinflussung des Mikrobioms durch Probiotika in der pädiatrischen Praxis. Monatsschr Kinderheilkd 2019 . 167:389-395
  • Härtel C, Pagel J, Spiegler J, Buma J, Henneke P, Zemlin M, Viemann D, Gille C, Gehring S, Frommhold D, Rupp J, Herting E, Göpel W. Lactobacillus acidophilus/Bifidobacteriuminfantis probiotics are associated with increasedgrowth of VLBWI among those exposed to antibiotics. Sci Rep. 2017 Jul17;7(1):5633. doi: 10.1038/s41598-017-06161-8.
  • Gehring S, Pietrzak-Nguyen A, Fichter M, Landfester K. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B? Nanomedicine(Lond). 2017 Jun;12(11):1205-1207. doi: 10.2217/nnm-2016-0064. Epub 2017 May 18.
  • Llano López LH, Reischl AT, Gröndahl B, Kidszun A, Kowalzik F, Oetzmann von Sochaczewski C, Gehring S. The BioFireFilmArray enables point of care diagnostic in neonatal parechovirus meningitis. Infect Dis (Lond). 2017 Apr 11:1-3. doi:10.1080/23744235.2017.1311417.
  • Knoll RL, Forslund K, Kultima JR, Meyer CU, Kullmer U, Sunagawa S, Bork P, Gehring S. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis. Am J Physiol Gastrointest Liver Physiol. 2017 Apr 1;312(4):G327-G339. doi: 10.1152/ajpgi.00293.2016.
  • Fichter M, Piradashvili K, Pietrzak-Nguyen A, Pretsch L, Kuhn G, Strand S, Knuf M, Zepp F, Wurm FR, Mailänder V, Landfester K, Gehring S. Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses. Biomaterials. 2016 Nov;108:1-12. doi:10.1016/j.biomaterials.2016.08.046. Epub 2016 Aug 31.
  • Pietrzak-Nguyen A, Piradashvili K, Fichter M, Pretsch L, Zepp F, Wurm FR, Landfester K, Gehring S. MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells. Nanomedicine. 2016 Nov;12(8):2383-2394. doi: 10.1016/j.nano.2016.07.010.
  • Welk A, Schmeh I, Knuf M, Groendahl B, Goebel J, Staatz G, Gawehn J, Gehring S. Acute Encephalopathy in Children Associated with Influenza A: A Retrospective Case Series. Klin Padiatr. 2016 Sep;228(5):280-1. doi: 10.1055/s-0042-111686.
  • Baier G, Fichter M, Kreyes A, Klein K, Mailänder V, Gehring S, Landfester K. Glutathione Responsive Hyaluronic Acid Nanocapsules Obtained by Bioorthogonal Interfacial "Click" Reaction. Biomacromolecules. 2016 Jan 11;17(1):148-53. doi: 10.1021/acs.biomac.5b01279. Epub 2015 Dec 16.
  • Baier, G.; Fichter, M.; Kreyes, A.; Klein, K.; Mailander, V.; Gehring, S.; Landfester, K. (2016): Glutathione Responsive Hyaluronic Acid Nanocapsules Obtained by Bioorthogonal Interfacial "Click" Reaction. In: Biomacromolecules 17 (1), S. 148–153. DOI: 10.1021/acs.biomac.5b01279.
  • Baier, G.; Winzen, S.; Messerschmidt, C.; Frank, D.; Fichter, M.; Gehring, S. et al. (2015): Heparin-based nanocapsules as potential drug delivery systems. In: Macromolecular bioscience 15 (6), S. 765–776. DOI: 10.1002/mabi.201500035.
  • Birkholz, J.; Doganci, A.; Darstein, C.; Gehring, S.; Zepp, F.; Meyer, C. U. (2014): IL-27 improves migrational and antiviral potential of CB dendritic cells. In: Hum Immunol 75 (6), S. 584–591. DOI: 10.1016/j.humimm.2014.02.004.
  • Bode, S. F.; Ammann, S.; Al-Herz, W.; Bataneant, M.; Dvorak, C. C.; Gehring, S. et al. (2015): The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. In: Haematologica 100 (7), S. 978–988. DOI: 10.3324/haematol.2014.121608.
  • Doganci, A.; Birkholz, J.; Gehring, S.; Puhl, A. G.; Zepp, F.; Meyer, C. U. (2013): In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells. In: Int Immunol 25 (3), S. 157–169. DOI: 10.1093/intimm/dxs097.
  • Du Prel, J. B.; Puppe, W.; Grondahl, B.; Knuf, M.; Weigl, J. A.; Schaaff, F.; Schmitt, H. J. (2009): Are meteorological parameters associated with acute respiratory tract infections? In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 49 (6), S. 861–868. DOI: 10.1086/605435.
  • Duwaerts, C. C.; Gehring, S.; Cheng, C. W.; van Rooijen, N.; Gregory, S. H. (2013): Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury. In: Liver Int 33 (2), S. 255–265. DOI: 10.1111/liv.12048.
  • Fichter, M.; Baier, G.; Dedters, M.; Pretsch, L.; Pietrzak-Nguyen, A.; Landfester, K.; Gehring, S. (2013): Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages. In: Nanomedicine 9 (8), S. 1223–1234. DOI: 10.1016/j.nano.2013.05.005.
  • Fichter, M.; Dedters, M.; Pietrzak-Nguyen, A.; Pretsch, L.; Meyer, C. U.; Strand, S. et al. (2015): Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage. In: Vaccine 33 (7), S. 838–846. DOI: 10.1016/j.vaccine.2014.12.072.
  • Gehring, S.; Dickson, E. M.; San Martin, M. E.; van Rooijen, N.; Papa, E. F.; Harty, M. W. et al. (2006): Kupffer cells abrogate cholestatic liver injury in mice. In: Gastroenterology 130 (3), S. 810–822. DOI: 10.1053/j.gastro.2005.11.015.
  • Gehring, S.; Gregory, S. H.; Wintermeyer, P.; San Martin, M.; Aloman, C.; Wands, J. R. (2008): Generation and characterization of an immunogenic dendritic cell population. In: J Immunol Methods 332 (1-2), S. 18–30. DOI: 10.1016/j.jim.2007.12.007.
  • Gehring, S.; Gregory, S. H.; Wintermeyer, P.; Aloman, C.; Wands, J. R. (2009): Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles. In: Clin Vaccine Immunol 16 (2), S. 163–171. DOI: 10.1128/CVI.00287-08.
  • Gehring, S.; Sabo, E.; San Martin, M. E.; Dickson, E. M.; Cheng, C. W.; Gregory, S. H. (2009): Laser capture microdissection and genetic analysis of carbon-labeled Kupffer cells. In: World J Gastroenterol 15 (14), S. 1708–1718.
  • Grondahl, B.; Ankermann, T.; Bismarck, P. von; Rockahr, S.; Kowalzik, F.; Gehring, S. et al. (2014): The 2009 pandemic influenza A(H1N1) coincides with changes in the epidemiology of other viral pathogens causing acute respiratory tract infections in children. In: Infection 42 (2), S. 303–308. DOI: 10.1007/s15010-013-0545-5.
  • Grondahl, B.; Puppe, W.; Hoppe, A.; Kuhne, I.; Weigl, J. A.; Schmitt, H. J. (1999): Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. In: Journal of clinical microbiology 37 (1), S. 1–7.
  • Grondahl, B.; Puppe, W.; Weigl, J.; Schmitt, H. J. (2005): Comparison of the BD Directigen Flu A+B Kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and respiratory syncytial virus. In: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 11 (10), S. 848–850. DOI: 10.1111/j.1469-0691.2005.01223.x.
  • Kalies, H.; Grote, V.; Siedler, A.; Grondahl, B.; Schmitt, H. J.; Kries, R. von (2008): Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure. In: Vaccine 26 (20), S. 2545–2552. DOI: 10.1016/j.vaccine.2008.03.001.
  • Kalies, H.; Siedler, A.; Grondahl, B.; Grote, V.; Milde-Busch, A.; Kries, R. von (2009): Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era. In: BMC infectious diseases 9, S. 45. DOI: 10.1186/1471-2334-9-45.
  • Kidszun, A.; Hansmann, A.; Winter, J.; Grondahl, B.; Knuf, M.; Weise, K.; Mildenberger, E. (2014): Detection of respiratory viral infections in neonates treated for suspicion of nosocomial bacterial sepsis: a feasibility study. In: The Pediatric infectious disease journal 33 (1), S. 102–104. DOI: 10.1097/INF.0000000000000008.
  • Kidszun, A.; Klein, L.; Winter, J.; Schmeh, I.; Grondahl, B.; Gehring, S. et al. (2016): Viral Infections in Neonates with Suspected Late-Onset Bacterial Sepsis-A Prospective Cohort Study. In: American journal of perinatology. DOI: 10.1055/s-0036-1584150.
  • Meyer, C. U.; Birkholz, J.; Weins, N.; Doganci, A.; Gehring, S.; Zepp, F.; Knuf, M. (2015): Dendritic cells change IL-27 production pattern during childhood. In: BMC Res Notes 8, S. 232. DOI: 10.1186/s13104-015-1182-0.
  • Meyer, C. U.; Kurlemann, G.; Sauter, M.; Wiemer-Kruel, A.; Hahn, A.; Doganci, A. et al. (2015): Inflammatory Characteristics of Monocytes from Pediatric Patients with Tuberous Sclerosis. In: Neuropediatrics 46 (5), S. 335–343. DOI: 10.1055/s-0035-1562925.
  • Pietrzak-Nguyen, A.; Fichter, M.; Dedters, M.; Pretsch, L.; Gregory, S. H.; Meyer, C. et al. (2014): Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules. In: Biomacromolecules 15 (7), S. 2378–2388. DOI: 10.1021/bm5006728.
  • Piradashvili, K.; Fichter, M.; Mohr, K.; Gehring, S.; Wurm, F. R.; Landfester, K. (2015): Biodegradable protein nanocontainers. In: Biomacromolecules 16 (3), S. 815–821. DOI: 10.1021/bm5016915.
  • Puppe, W.; Weigl, J. A.; Aron, G.; Grondahl, B.; Schmitt, H. J.; Niesters, H. G.; Groen, J. (2004): Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. In: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 30 (2), S. 165–174. DOI: 10.1016/j.jcv.2003.10.003.
  • Puppe, W.; Weigl, J.; Grondahl, B.; Knuf, M.; Rockahr, S.; Bismarck, P. von et al. (2013): Validation of a multiplex reverse transcriptase PCR ELISA for the detection of 19 respiratory tract pathogens. In: Infection 41 (1), S. 77–91. DOI: 10.1007/s15010-012-0298-6.
  • Schmitt, Heinz-J.; Gröndahl, Britta; Schaaff, Franziska; Puppe, Wolfram (2007): The beginning of a new era. Systematic testing for pathogens causing acute respiratory tract infections (ARI) in children. In: J Pediatr (Rio J) 83 (5), S. 391–394. DOI: 10.2223/JPED.1701.
  • Weigl, J. A.; Puppe, W.; Grondahl, B.; Schmitt, H. J. (2000): Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction. In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19 (5), S. 336–343.
  • Wintermeyer, P.; Cheng, C. W.; Gehring, S.; Hoffman, B. L.; Holub, M.; Brossay, L.; Gregory, S. H. (2009): Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage. In: Gastroenterology 136 (3), S. 1048–1059. DOI: 10.1053/j.gastro.2008.10.027.


































Klinik und Poliklinik für Kinder- und Jugendmedizin

Universitätsmedizin Mainz
Klinik und Poliklinik für Kinder- und Jugendmedizin

Gebäude 109

Langenbeckstr. 1

55131 Mainz

Tel.: 06131 17-2557


AG Pädiatrische Immunologie und Impfstoffentwicklung

Klinik und Poliklinik für Kinder- und Jugendmedizin
Labor für Pädiatrische Immunologie

Universitätsmedizin Mainz
Verfügungsgebäude 911/R.01-336
Obere Zahlbacher Str. 63
55131 Mainz

Tel.: +49 6131 17-9753
Fax: +49 6131 17-9658